Physician profile
Bruce Mark Brenner
NPI 1699726125
$1,964.50
in general payments reported to CMS, 2019-2025
15 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $621 · 2020: $210 · 2021: $297 · 2022: $53.90 · 2023: $132 · 2024: $240 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $443.91 | 2019 | |
| Cook Medical LLC | $285.47 | 2024-2025 | Cook, Zenith Alpha |
| Baxter Healthcare | $271.99 | 2021 | |
| Intuitive Surgical, INC. | $227.79 | 2019-2020 | |
| Abbvie INC. | $148.55 | 2022-2023 | Strattice Reconstructive Tissue Matrix Bps |
| Cvrx, INC. | $128.71 | 2025 | Barostim Neo System |
| Pacira Pharmaceuticals Incorporated | $120.85 | 2025 | Exparel |
| Abbott Laboratories | $66.67 | 2019 | |
| Boston Scientific Corporation | $62.55 | 2021-2022 | |
| Ethicon US, LLC | $52.26 | 2019 | |
| Inari Medical, INC. | $45.49 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $40.35 | 2019 | |
| Solventum Corporation | $28.49 | 2025 | V.A.C. Veraflo, Abthera, Prevena |
| Takeda Pharmaceuticals U.S.A., INC. | $22.06 | 2024 | Gattex |
| Avita Medical Americas, LLC | $19.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.